Bill Bradford

Dr. Bradford has over 20 years of experience in the biopharma industry in executive, development, and medical affairs roles, ranging from preclinical and clinical development to drug approval and post-marketing programs. Currently Chief Medical Officer (CMO) and Director at Indalo Therapeutics, Director at The Bluefield Project, and Principle at WZB Consulting. Previously Founder at Cascadia Therapeutics, SVP Clinical Development at InterMune, and held clinical positions at IntraBiotics Pharmaceuticals and Genentech. Dr. Bradford trained in internal medicine and infectious diseases and practiced academic medicine in the Division of Infectious Diseases at the University of California, San Francisco. He received his Ph.D. in epidemiology from the University of California, Berkeley, his M.D. from the University of North Carolina, Chapel Hill, and his B.A. from Williams College. He is an author on over 40 peer-reviewed scientific publications and an inventor on 16 issued US patents.